ESE Clinical Practice Guideline: Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition - ESE | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
ESE
2022
ESE Clinical Practice Guideline: Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition
Document
Analyser ce document
